MedPath

Incheon-Bucheon Cohort of Patients Undergoing Primary PCI for Acute STEMI

Completed
Conditions
Myocardial Infarction
Interventions
Procedure: STEMI treated with primary PCI
Registration Number
NCT02804958
Lead Sponsor
Gachon University Gil Medical Center
Brief Summary

INcheon-Bucheon cohorT of patients undERgoing primary percutaneous coronary intervention for acute ST-ELevation myocardiaL infARction (INTERSTELLAR) registry is a retrospective, observational, 4-regional-hospital based registry reflecting current practices of management, risk factors, and clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention at cities of Incheon and Bucheon located in the mid-western part of the Korean peninsula between 2007 and 2014.

Detailed Description

INcheon-Bucheon cohorT of patients undERgoing primary percutaneous coronary intervention for acute ST-ELevation myocardiaL infARction (INTERSTELLAR) registry is a retrospective, observational, 4-regional-hospital based registry reflecting current practices of management, risk factors, and clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) at cities of Incheon and Bucheon located in the mid-western part of the Korean peninsula between 2007 and 2014. Diagnosis of acute STEMI was based on clinical data findings including typical symptoms, 12-lead electrocardiography, and blood test. Decisions regarding primary PCI were made by at least 2 attending cardiologists at the time of presentation.

Demographic data, cardiovascular risk factors, laboratory data and clinical follow-up data were collected. Baseline blood test was obtained and recorded as part of the routine care for patients who visited the emergency room for chest pain and in whom acute coronary syndrome was suspected. Standard medical management was provided by responsible physicians.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1537
Inclusion Criteria
  • Patients diagnosed with acute ST-segment elevation myocardial infarction
  • Patients treated with primary percutaneous coronary intervention
Exclusion Criteria
  • Patients diagnosed with Non-ST-segment elevation acute coronary syndrome
  • Patients treated with thrombolytic therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
STEMI treated with primary PCISTEMI treated with primary PCIPatients diagnosed with acute ST-segment elevation myocardial infarction and treated with primary percutaneous coronary intervention were consecutively registered.
Primary Outcome Measures
NameTimeMethod
MACCEWithin the 1 year

Major adverse cardiac and cerebrovascular event (MACCE), defined as the composite of all-cause death, non-fatal myocardial infarction and non-fatal stroke

Secondary Outcome Measures
NameTimeMethod
Ischemic-driven revascularizationWithin the 1 year
Admission for heart failureWithin the 1 year
Non-fatal myocardial infarctionWithin the 1 year
Non-fatal strokeWithin the 1 year
All-cause deathWithin the 1 year

Trial Locations

Locations (4)

Soon Chun Hyang University Bucheon Hospital

🇰🇷

Bucheon, Korea, Republic of

Sejong General Hospital

🇰🇷

Bucheon, Korea, Republic of

Gachon University Gil Medical Center

🇰🇷

Incheon, Korea, Republic of

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath